pharmaphorum

MAY 18, 2021

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. Data were announced at the virtual American College of Cardiology annual conference and published simultaneously in The Lancet.

Drugs 52

Drugs Cardiology Trials Clinical Trials 52

The Pharma Data

JANUARY 20, 2021

He currently serves on the Acute Heart Failure Committee of the European Society of Cardiology Heart Failure Association and has served on the National Committee on Heart Failure and Transplantation of the American Heart Association. Dr. Teerlink was profiled in The Lancet as an internationally recognized leader in heart failure.

Trials 52

Trials Cardiology Containment Development 52

The Pharma Data

MARCH 13, 2022

(NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

Dermatology 52

Dermatology Cardiology Development Medicine 52

Drug Discovery World

OCTOBER 19, 2022

The drop in recruiting sites in Ukraine and in Russia sadly confirms our earlier prediction that the impact of war in the region on clinical development, and most importantly on patients, is considerable. Clinic+, based in the capital Kyiv, where fighting has been particularly severe since the start of the war. .

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Delveinsight

JULY 22, 2021

Joachim Fruebis, chief development officer of BlueRock, said that receiving fast track designation from the FDA is a crucial step, which will help them further progress clinical development of their DA01 cell therapy approach for Parkinson’s disease.

Cardiology 98

Cardiology Development Engineer Clinical Trials 98

The Pharma Data

MAY 31, 2022

Senior Vice President, Clinical Development, BlueRock Therapeutics. “We We are excited that our Phase 1 clinical trial has completed enrollment and believe it is a critical next step toward the development of a novel cell therapy that has the potential to transform the treatment landscape for this devastating disease.”.

Trials 52

Trials Engineer Clinical Trials Clinical Trials 52

The Pharma Data

JULY 12, 2021

The clinical data from FIGARO-DKD are scheduled for presentation at the European Society of Cardiology (ESC) Congress 2021 on August 28th. The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development.

FDA Approval 52

FDA Approval Cardiology Medicine Trials 52

The Pharma Data

NOVEMBER 8, 2021

The cardiology ballot at Bayer formerly includes a number of products and several other composites in colorful stages of preclinical and clinical development.

Clinical Trials 52

Clinical Trials Clinical Trials Trials HR 52

The Pharma Data

NOVEMBER 5, 2021

EMPEROR Program clinical investigator and Emeritus Professor of Rectifiers and Cardiology at the University of Lorraine, France.”The vice chairman, Clinical Development & Medical Affairs, Cardio-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals,Inc.”The

Trials 52

Trials Cardiology Drugs Development 52

The Pharma Data

AUGUST 30, 2021

Professor of Cardiology at the National and Kapodistrian University of Athens, Greece, and co-principal investigator of the FIDELIO-DKD and FIGARO-DKD Phase III clinical trials. The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development.

HR 52

HR Cardiology Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 28, 2021

The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Branding 52

The Pharma Data

SEPTEMBER 11, 2021

Results from EMPEROR-Preserved were presented at the European Society of Cardiology Congress 2021 on August 27 and published in The New England Journal of Medicine. vice president, Clinical Development & Medical Affairs, Cardio-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals, Inc.

Medicine 52

Medicine Insulin FDA Approval Trials 52

The Pharma Data

NOVEMBER 11, 2021

The companies partake inversely the costs of the development of vericiguat. About Cardiology at Bayer Bayer is an invention leader in the area of cardiovascular conditions, with a long-standing commitment to delivering wisdom for a better life by advancing a portfolio of innovative treatments.

Cardiology 40

Cardiology Branding Development Production 40

XTalks

NOVEMBER 19, 2021

This is a part of the precision cardiology approach and could lead to their use as prognostic indicators. Full-Service Clinical Development. The Double-Edged Sword of Cardiac Biomarkers.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

The Pharma Data

DECEMBER 12, 2020

AstraZeneca , with Alexion ‘s R&D team, will work to build on Alexion ‘s pipeline of 11 molecules across more than 20 clinical-development programmes across the spectrum of indications, in rare diseases and beyond. The FcRn extends the half-life and hence the availability of pathogenic immunoglobulin G (IgG) antibodies.

Development 75

Development Regulation Medicine Containment 75

XTalks

JANUARY 19, 2024

Accelerating Global Radiopharmaceutical Clinical Development To arrive at success in your radiopharmaceutical development, it takes a team-based approach to drive evidence-based clinical decisions. References The Green Journal. Radiotherapy and Oncology.

DNA 66

DNA Radiology FDA Approval Development 66

pharmaphorum

OCTOBER 8, 2020

Clinical development of the system got off the ground last year when the company announced the closure of a £2.15m financing round. The primary goals are freedom from AF without anti-arrhythmia drugs at 12 months and response to STAR guided ablation during the procedure – either a slowing or termination of AF.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Development 52

The Pharma Data

JULY 8, 2021

. “No approved therapies have been clinically proven to improve outcomes specifically for people with HFpEF, leaving a significant unmet medical need in this already prevalent and increasingly common form of heart failure,” said Mohamed Eid, M.D., vice president, Product Development, Lilly.

Trials 52

Trials Doctors Doctor Medicine 52

The Pharma Data

SEPTEMBER 15, 2020

In addition to the COVID-19 vaccine program, Pfizer aims to deliver five innovative vaccines by 2025, subject to clinical success and regulatory approval. 20vPnC showed a safety and tolerability profile that was similar to Prevnar 13 ® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]. and -50.4%

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. Astellas Pharma Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98